JP2019526584A5 - - Google Patents

Download PDF

Info

Publication number
JP2019526584A5
JP2019526584A5 JP2019512280A JP2019512280A JP2019526584A5 JP 2019526584 A5 JP2019526584 A5 JP 2019526584A5 JP 2019512280 A JP2019512280 A JP 2019512280A JP 2019512280 A JP2019512280 A JP 2019512280A JP 2019526584 A5 JP2019526584 A5 JP 2019526584A5
Authority
JP
Japan
Prior art keywords
subject
composition
spinal cord
cord injury
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019512280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526584A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/051677 external-priority patent/WO2018053210A1/en
Publication of JP2019526584A publication Critical patent/JP2019526584A/ja
Publication of JP2019526584A5 publication Critical patent/JP2019526584A5/ja
Priority to JP2022096318A priority Critical patent/JP2022130483A/ja
Priority to JP2024061113A priority patent/JP2024096794A/ja
Pending legal-status Critical Current

Links

JP2019512280A 2016-09-14 2017-09-14 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞 Pending JP2019526584A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022096318A JP2022130483A (ja) 2016-09-14 2022-06-15 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞
JP2024061113A JP2024096794A (ja) 2016-09-14 2024-04-04 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662394226P 2016-09-14 2016-09-14
US62/394,226 2016-09-14
US201762449580P 2017-01-23 2017-01-23
US62/449,580 2017-01-23
US201762518591P 2017-06-12 2017-06-12
US62/518,591 2017-06-12
PCT/US2017/051677 WO2018053210A1 (en) 2016-09-14 2017-09-14 Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022096318A Division JP2022130483A (ja) 2016-09-14 2022-06-15 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞

Publications (2)

Publication Number Publication Date
JP2019526584A JP2019526584A (ja) 2019-09-19
JP2019526584A5 true JP2019526584A5 (enExample) 2020-11-12

Family

ID=61620153

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019512280A Pending JP2019526584A (ja) 2016-09-14 2017-09-14 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞
JP2022096318A Pending JP2022130483A (ja) 2016-09-14 2022-06-15 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞
JP2024061113A Pending JP2024096794A (ja) 2016-09-14 2024-04-04 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022096318A Pending JP2022130483A (ja) 2016-09-14 2022-06-15 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞
JP2024061113A Pending JP2024096794A (ja) 2016-09-14 2024-04-04 脊髄損傷の治療のための多能性幹細胞由来オリゴデンドロサイト前駆細胞

Country Status (7)

Country Link
US (1) US20190262405A1 (enExample)
EP (1) EP3518945A4 (enExample)
JP (3) JP2019526584A (enExample)
CN (1) CN109715175A (enExample)
AU (1) AU2017326424B2 (enExample)
CA (1) CA3036832A1 (enExample)
WO (1) WO2018053210A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12365872B2 (en) 2018-09-19 2025-07-22 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture
CN115667503A (zh) * 2020-05-01 2023-01-31 儿童医疗中心有限公司 促进髓鞘化的组合物和方法
EP4284397A4 (en) * 2021-01-28 2025-04-16 Asterias Biotherapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURIES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285415B2 (en) * 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
AR046076A1 (es) * 2003-07-18 2005-11-23 Otsuka Pharma Co Ltd Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida

Similar Documents

Publication Publication Date Title
PH12017501097A1 (en) Sunitinib formulations and methods for use thereof in treatment of ocular disorders
BRPI0708576A2 (pt) composição compreedendo células-tronco embriÈnicas humanas e seus derivados, métodos de uso e métodos de preparação
CA2747794A1 (en) Treatment of lung and pulmonary diseases and disorders
Abi Chahine et al. Treatment of cerebral palsy with stem cells: a report of 17 cases
JP2019526584A5 (enExample)
CN103340890A (zh) Nadph作为制备用于防治脑缺血性中风药物方面的应用
Sun et al. Bioactive peptide hydrogel scaffold with high fluidity, thermosensitivity, and neurotropism in 3D spatial structure for promoted repair of spinal cord injury
Alvites et al. Biomaterials and cellular systems at the forefront of peripheral nerve regeneration
US20220354779A1 (en) Nanofiber- and nanowhisker-based transfection platforms
CN104116968A (zh) 一种具有镇静安神治疗失眠的中药制剂
JP2013523776A5 (enExample)
HRP20151320T1 (hr) Kompozicija päśelinjeg meda i l-alanil-l-glutamina
RU2009129507A (ru) Способ лечения онкологических заболеваний
CN105012292A (zh) 一种药物组合物及其用途
CN104173383A (zh) 蚯蚓提取物的药物用途
CA2693382A1 (en) Fused stem cells useful for the treatment of diabetes and methods thereof
JP2008531698A5 (enExample)
WO2016074117A1 (zh) 一种治疗肾虚的药物组合物及其制备方法
CN102512650A (zh) 一种治疗面神经麻痹的外用药物
ES2748475T3 (es) Composiciones que comprenden células madre embrionarias humanas y sus derivados, procedimientos de uso y procedimientos de preparación
ES2963860T3 (es) Producto farmacéutico para su uso en el tratamiento de la enfermedad de Alzheimer
Fakheri et al. Evaluation of lithium chronic effects on thyroid tissues and its secreted hormones in female rats.
CN103706041B (zh) 用于血管和多发性硬化的磁贴
US20090105154A1 (en) Composition for prevention or treatment of gastrointestinal damage
CN106138072A (zh) 基于积雪草苷的治疗抑郁症复合药物